New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances

被引:31
作者
Hunfeld, KP [1 ]
Kraiczy, P [1 ]
Wichelhaus, TA [1 ]
Schäfer, V [1 ]
Brade, V [1 ]
机构
[1] Univ Hosp Frankfurt, Inst Med Microbiol, D-60596 Frankfurt, Germany
关键词
D O I
10.1007/s100960050005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A newly developed colorimetric microdilution method was used to analyze the activity of 12 antimicrobial agents against nine Borrelia burgdorferi isolates, including all three genospecies pathogenic for humans. In addition, in vitro antimicrobial resistance patterns of Borrelia valaisiana and Borrelia bissettii tick isolates were investigated. The applied test system is based upon color changes that occur in the presence of phenol red and result from the accumulation of nonvolatile acid produced by actively metabolizing spirochetes. After 72 h of incubation, minimal inhibitory concentrations (MICs) were determined from the decrease of absorbance by software-assisted calculation of growth curves. MIC values were lowest for azlocillin (MIC, less than or equal to 0.125 mu g/ml), ceftriaxone (MIC range, less than or equal to 0.015-0.06 mu g/ml), and azithromycin (MIC range, less than or equal to 0.015-0.06 mu g/ml). Whereas tobramycin (MIC range, 8-64 mu g/ml) exhibited little activity, spectinomycin (MIC range, 0.25-2 mu g/ml) showed in vitro antimicrobial activity against Borrelia burgdorferi. The MICs of penicillin G for Borrelia afzelii isolates were ten times higher than those for Borrelia burgdorferi, Borrelia valaisiana, and Borrelia bissettii isolates (P<0.05) and 100 times higher than those for isolates belonging to the genospecies Borrelia garinii (P<0.05). Further significant differences with respect to the MIC values of the other antimicrobial agents tested were not noted. The colorimetric microdilution method offered the advantages of reliability, reproducibility, and convenience and could handle large numbers of isolates and antibiotics.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 24 条
[11]   CEFOTAXIME VERSUS PENICILLIN IN THE LATE STAGE OF LYME-DISEASE - PROSPECTIVE, RANDOMIZED THERAPEUTIC STUDY [J].
HASSLER, D ;
ZOLLER, L ;
HAUDE, M ;
HUFNAGEL, HD ;
HEINRICH, F ;
SONNTAG, HG .
INFECTION, 1990, 18 (01) :16-20
[12]   COMPARATIVE INVITRO AND INVIVO SUSCEPTIBILITIES OF THE LYME-DISEASE SPIROCHETE BORRELIA-BURGDORFERI TO CEFUROXIME AND OTHER ANTIMICROBIAL AGENTS [J].
JOHNSON, RC ;
KODNER, CB ;
JURKOVICH, PJ ;
COLLINS, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (11) :2133-2136
[13]  
Kraiczy P, 1998, WIEN KLIN WOCHENSCHR, V110, P886
[14]   IN-VITRO SUSCEPTIBILITY OF BORRELIA-BURGDORFERI TO 11 ANTIMICROBIAL AGENTS [J].
LEVIN, JM ;
NELSON, JA ;
SEGRETI, J ;
HARRISON, B ;
BENSON, CA ;
STRLE, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (07) :1444-1446
[15]   A SIMPLE, COLORIMETRIC MICROTITER ASSAY FOR BORRELIACIDAL ACTIVITY OF ANTISERA [J].
MA, JN ;
COUGHLIN, RT .
JOURNAL OF MICROBIOLOGICAL METHODS, 1993, 17 (02) :145-153
[16]   Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants [J].
Mursic, VP ;
Wanner, G ;
Reinhardt, S ;
Wilske, B ;
Busch, U ;
Marget, W .
INFECTION, 1996, 24 (03) :218-226
[17]  
NCCLS, 1999, M100S9 NCCLS, pM100
[18]   Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing [J].
Pfaller, MA ;
Arikan, S ;
Lozano-Chiu, M ;
Chen, YS ;
Coffman, S ;
Messer, SA ;
Rennie, R ;
Sand, C ;
Heffner, T ;
Rex, JH ;
Wang, J ;
Yamane, N .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (09) :2609-2612
[19]  
PREACMURSIC V, 1986, ZBL BAKT-INT J MED M, V263, P112
[20]  
PREACMURSIC V, 1987, EUR J CLIN MICROBIOL, V6, P424